• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用丙咪嗪对女性压力性尿失禁进行保守治疗。

Conservative treatment of female stress incontinence with imipramine.

作者信息

Gilja I, Radej M, Kovacić M, Parazajder J

出版信息

J Urol. 1984 Nov;132(5):909-11. doi: 10.1016/s0022-5347(17)49941-1.

DOI:10.1016/s0022-5347(17)49941-1
PMID:6541710
Abstract

The results of a clinical study of conservative treatment of women with stress incontinence are presented. A daily dose of 75 mg. imipramine hydrochloride was given for 4 weeks. Special attention was paid to the effects of imipramine on the functional urethral length and maximum urethral closure pressure. A total of 21 women (71 per cent) stated that they were continent after treatment with imipramine, while 9 (29 per cent) did not improve and treatment was stopped. According to our results, imipramine extended the functional urethral length and made it independent of stress factors in women who were continent after treatment with imipramine. In patients with persistent incontinence the functional urethral length was extended significantly but was shortened with stress despite imipramine therapy. We believe that imipramine could be an alternative treatment in selected cases with stress incontinence.

摘要

本文介绍了压力性尿失禁女性保守治疗的临床研究结果。给予盐酸丙咪嗪每日剂量75毫克,持续4周。特别关注丙咪嗪对功能性尿道长度和最大尿道闭合压的影响。共有21名女性(71%)表示在接受丙咪嗪治疗后不再尿失禁,而9名(29%)没有改善,治疗停止。根据我们的结果,丙咪嗪延长了功能性尿道长度,并使其在接受丙咪嗪治疗后不再尿失禁的女性中不受压力因素影响。在持续性尿失禁患者中,功能性尿道长度虽显著延长,但尽管接受了丙咪嗪治疗,在压力状态下仍会缩短。我们认为,在某些压力性尿失禁病例中,丙咪嗪可能是一种替代治疗方法。

相似文献

1
Conservative treatment of female stress incontinence with imipramine.用丙咪嗪对女性压力性尿失禁进行保守治疗。
J Urol. 1984 Nov;132(5):909-11. doi: 10.1016/s0022-5347(17)49941-1.
2
Comparison of treatment outcomes for imipramine for female genuine stress incontinence.
Br J Obstet Gynaecol. 1999 Oct;106(10):1089-92. doi: 10.1111/j.1471-0528.1999.tb08119.x.
3
Effect of imipramine on urethral opening pressure: A randomized, double-blind, placebo-controlled crossover study in healthy women.度洛西汀对尿道开口压的影响:健康女性中一项随机、双盲、安慰剂对照交叉研究。
Neurourol Urodyn. 2019 Apr;38(4):1076-1080. doi: 10.1002/nau.23955. Epub 2019 Mar 7.
4
Effect of propiverine hydrochloride on stress urinary incontinence.盐酸丙哌维林对压力性尿失禁的影响。
Int J Urol. 2014 Oct;21(10):1022-5. doi: 10.1111/iju.12513. Epub 2014 Jun 16.
5
The effects of long-term treatment with norephedrine on stress incontinence and urethral closure pressure profile.去甲麻黄碱长期治疗对压力性尿失禁和尿道闭合压曲线的影响。
Scand J Urol Nephrol. 1978;12(2):105-10. doi: 10.3109/00365597809179974.
6
Measurement of urethral closure function in women with stress urinary incontinence.压力性尿失禁女性尿道闭合功能的测量
J Urol. 2009 Jun;181(6):2628-33; discussion 2633. doi: 10.1016/j.juro.2009.01.114. Epub 2009 Apr 16.
7
[Definition and etiologic factors of hypotonic urethra in relation to urinary stress incontinence in the female].[女性压力性尿失禁相关的低张性尿道的定义及病因]
Geburtshilfe Frauenheilkd. 1989 Oct;49(10):857-64. doi: 10.1055/s-2008-1036100.
8
[The static and dynamic profiles of urethral pressure in women with stress incontinence and in healthy controls].[压力性尿失禁女性与健康对照者的尿道压力静态和动态特征]
Akush Ginekol (Sofiia). 1994;33(3):19-21.
9
Urethral pressure profiles before and after Ornade administration in patients with stress urinary incontinence.
J Urol. 1979 Aug;122(2):198-9. doi: 10.1016/s0022-5347(17)56327-2.
10
The effects of estrogens and gestagens on the urethral pressure profile in urinary continent and stress incontinent women.雌激素和孕激素对尿失禁和压力性尿失禁女性尿道压力曲线的影响。
Acta Obstet Gynecol Scand. 1980;59(3):265-70. doi: 10.3109/00016348009155409.

引用本文的文献

1
Pharmacotherapy in Stress Urinary Incontinence; A Literature Review.压力性尿失禁的药物治疗:文献综述。
Curr Urol Rep. 2024 Jul;25(7):141-148. doi: 10.1007/s11934-024-01205-9. Epub 2024 May 10.
2
Medical management of stress urinary incontinence: is there a future?压力性尿失禁的医学管理:未来会怎样?
Curr Urol Rep. 2009 Sep;10(5):401-7. doi: 10.1007/s11934-009-0063-2.
3
Dilemmas in the management of female stress incontinence: the role of pelvic floor muscle training.女性压力性尿失禁管理中的困境:盆底肌训练的作用
Int Urol Nephrol. 2006;38(3-4):513-25. doi: 10.1007/s11255-006-0085-3. Epub 2006 Nov 29.
4
Duloxetine: a new pharmacologic therapy for stress urinary incontinence.度洛西汀:一种治疗压力性尿失禁的新型药物疗法。
Rev Urol. 2004;6 Suppl 3(Suppl 3):S48-55.
5
Treatment options for stress urinary incontinence.压力性尿失禁的治疗选择。
Rev Urol. 2004;6 Suppl 3(Suppl 3):S29-47.
6
Pharmacotherapy for stress urinary incontinence : present and future options.压力性尿失禁的药物治疗:现状与未来选择
Drugs. 2004;64(14):1503-16. doi: 10.2165/00003495-200464140-00001.
7
Urinary incontinence in the elderly. Drug treatment options.老年人尿失禁。药物治疗选择。
Drugs. 1998 Oct;56(4):587-95. doi: 10.2165/00003495-199856040-00006.
8
Current concepts in the treatment of disorders of micturition.排尿障碍治疗的当前概念
Drugs. 1988 Apr;35(4):477-94. doi: 10.2165/00003495-198835040-00006.